Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates
Provided By GlobeNewswire
Last update: May 5, 2025
Cash runway extended into 2029
Initiation of Phase 3 ReDiscover-2 trial on track for mid-2025
Initiated Phase 1 RLY-2608 vascular malformations clinical trial in Q1
Read more at globenewswire.com
